Previous Article | Next Article 
Journal of Virology, May 1999, p. 4299-4304, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Disruption of Nucleotide Excision Repair by the
Human T-Cell Leukemia Virus Type 1 Tax Protein
Shyan-Yuan
Kao and
Susan J.
Marriott*
Division of Molecular Virology, Baylor
College of Medicine, Houston, Texas 77030
Received 16 September 1998/Accepted 1 February 1999
 |
ABSTRACT |
The Tax protein of human T-cell leukemia virus type 1 (HTLV-1) is a
transcriptional transactivator and viral oncogene. Since cellular
transformation has been frequently linked to alterations in genome
stability, we investigated the effect of Tax on nucleotide excision
repair (NER), a prominent cellular DNA repair pathway. Cells expressing
Tax exhibited a reduced capacity for NER as measured by unscheduled DNA
synthesis and host cell reactivation assays. The cellular proliferating
cell nuclear antigen (PCNA) gene product regulates DNA replication and
repair pathways, including NER. Since Tax activates transcription of
the PCNA promoter, we investigated whether this activity contributes to
the reduction of NER. Tax increased endogenous PCNA protein expression,
and analysis of Tax mutant proteins demonstrated that the reduction in
NER correlated with Tax transactivation of PCNA gene expression. Direct
overexpression of PCNA also reduced NER. We propose that overexpression
of PCNA, and disruption of NER induced by Tax, predisposes cells to
accumulate DNA damage and contributes to HTLV-1 transformation.
 |
INTRODUCTION |
Human T-cell leukemia virus type 1 (HTLV-1) infects and transforms CD4+ T lymphocytes and is
the etiologic agent of adult T-cell leukemia (ATL) (25). ATL
develops in less than 5% of HTLV-1-infected individuals after a
relatively long period of clinical latency lasting 2 or more decades
(13). Cytogenetic studies of leukemic cells from ATL
patients and of cells transformed with HTLV-1 in vitro have revealed
clonal chromosomal abnormalities, most commonly involving deletions and
translocations (6, 10, 16, 20, 22, 29). Although chromosomal
changes are common in transformed ATL cells, no consistent
abnormalities have been found in all ATL patients. These features
suggest that accumulation of DNA damage induced by generalized
deregulation of host DNA replication or repair contributes to the
development of ATL.
The HTLV-1 Tax protein independently immortalizes T lymphocytes
(11) and transforms rat fibroblasts (12, 26, 33). Cellular transformation by Tax is thought to involve a multistep pathway including induction of cell proliferation and accumulation of
genetic damage. Effects of Tax on DNA repair have not been previously
reported but are suggested by its ability to suppress expression of
human DNA polymerase
, an enzyme involved in base excision repair
(15), and the presence of micronuclei in Tax-expressing cells (21, 30).
Recently, we have shown that Tax can transactivate the proliferating
cell nuclear antigen (PCNA) promoter (28). PCNA increases the processivity of DNA polymerase (Pol)
, an enzyme involved in
both DNA replication and repair (17). In the presence of DNA
damage, elevated levels of the cyclin-dependent kinase inhibitor p21
interact directly with PCNA and block PCNA-dependent DNA replication without interfering with PCNA-dependent DNA repair (30, 34). Excess PCNA can overcome the p21 block of DNA replication
(18), allowing DNA Pol
synthesis past template lesions
and resulting in increased nucleotide misincorporation rates
(23).
The goal of this study was to determine the effects of Tax on cellular
DNA repair synthesis. The results demonstrate that Tax inhibits
nucleotide excision repair (NER), a prominent cellular DNA repair
pathway, and that this effect correlates with Tax activation of PCNA
gene expression. We further demonstrate that direct overexpression of
PCNA also reduces NER. These activities may provide a mechanism for
accumulation of chromosomal damage in HTLV-1-infected cells.
 |
MATERIALS AND METHODS |
Plasmids.
The PCNA cDNA from pGex-2T-PCNA (24)
was cloned into pcDNA3.1Zeo(
) (Invitrogen) to create the PCNA
expression plasmid. Antisense PCNA (ANCP) was created by cloning PCNA
cDNA in the reverse orientation into pcDNA3.1Zeo(
). Tax expression
plasmid pCMV-Tax and the mutant Tax expression plasmids used have been previously described (31). Plasmids
397PCNA-CAT, pSV-Tax,
pMSV-Luc, and pSV-Tax
HC have been previously described
(28).
Transfections.
REF52 cells were grown in 60-mm-diameter
dishes and transfected by calcium phosphate precipitation with a total
of 14 µg of DNA, which included 1 µg of the pMSV-Luc plasmid, 4 µg of the
397PCNA-CAT reporter plasmid, and 6 µg of Tax
expression vectors. Cells were harvested 72 h posttransfection and
resuspended in 400 µl of reporter lysis buffer (Promega). The cell
pellet was disrupted by a single freeze-thaw cycle.
CAT and luciferase assays.
Chloramphenicol acetyltransferase
(CAT) assays were performed by a single-phase extraction assay
(28). Briefly, 25 µl of the total cell extract was added
to a mixture of 50 µl of water, 10 µl of 1 M Tris (pH 7.4), 10 µl
of 2.5 mM n-butyryl-coenzyme A, and 5 µl of
xylene-extracted [3H]chloramphenicol (NEN) at 0.2 µCi/reaction. The CAT assay mixture was incubated overnight at 37°C
and extracted with 200 µl of 2,6,10,14-tetramethylpentadecane and
xylene (2:1). The organic phase was then scintillation counted. For
luciferase assays, 25 µl of the total cell extract was added to 50 µl of luciferase substrate (Promega). Luciferase activity was
quantitated in a Turner TD-20e luminometer.
Unscheduled DNA synthesis (UDS) assay.
Duplicate
60-mm-diameter dishes of confluent REF52 cells were transfected with a
control plasmid (pSV2-neo or pCMV-1), a Tax expression plasmid (pSV-Tax
or pCMV-Tax), or mutant Tax (M3, M21, M32, or M47) together with 1 µg
of a luciferase reporter plasmid (pMSV-Luc) to control for transfection
efficiency. To eliminate background semiconservative DNA replication,
48 h after transfection the cells were cultured in 0.5% serum for
3 h and 10 mM hydroxyurea was added 1 h before irradiation.
One of the duplicate plates was then irradiated with UVC light (254 nm,
30 J/m2) by using a Stratalinker (Stratagene). The other
plate was mock irradiated, and both plates were labeled with medium
containing [3H]thymidine (5 µCi/ml; ICN Radiochemicals)
for 2 h in the continued presence of 10 mM hydroxyurea. The cells
were lysed by freeze-thawing in 400 µl of reporter lysis buffer
(Promega) and transferred to 1.5-ml microcentrifuge tubes. A 50-µl
aliquot was removed for analysis of luciferase activity, and the
remaining DNA was precipitated by adding cold 100% trichloroacetic
acid to a final concentration of 5%, and incubation at 4°C
overnight. [3H]thymidine incorporation was measured by
spotting the precipitated DNA onto glass fiber filters (GF/C; Whatman),
sequential washing with 10 and 5% trichloroacetic acid, and counting
in a Beckman scintillation counter. [3H]thymidine values
for each plate were divided by luciferase activity to correct for
transfection efficiency. The corrected [3H]thymidine
value for each nonirradiated plate was set to 100%, and its irradiated
partner was adjusted correspondingly so that different plasmid
transfections could be compared. The adjusted [3H]thymidine value from irradiated cells that received
the control plasmid was set to 100% repair activity, and the relative
[3H]thymidine values from each test plasmid were reported
as percent repair activity.
Host cell reactivation (HCR) assay.
The pMSV-Luc reporter
plasmid was damaged in vitro by exposure to UVC light (254 nm) at 1,000 J/m2. REF52 cells or cloned rat embryo fibroblasts (CREF)
were transfected with 4 µg of a UV-damaged or a control nonirradiated
pMSV-Luc plasmid together with 4 µg of pSV2-CAT (to control for
transfection efficiency). Certain plates also received plasmids
encoding wild-type Tax, mutant Tax, or PCNA to test the effects of
these gene products on DNA repair. Forty-eight hours after
transfection, cells were lysed and luciferase activity was measured.
Luciferase activity was normalized to the CAT activity of the same
plate. Since UV damage reduces luciferase expression from pMSV-Luc, the
level of normalized luciferase activity represents the degree of DNA repair. Normalized luciferase activity from each nonirradiated plate
was set to 100%, and its irradiated partner was adjusted correspondingly so that different plasmid transfections could be
compared. The adjusted luciferase value from irradiated cells that
received the control plasmid was set to 100% repair activity, and the
corrected luciferase values from each test plasmid were reported as
percent repair activity.
 |
RESULTS |
Disruption of nucleotide excision repair by Tax.
The effect of
Tax on cellular DNA repair was investigated by using a UDS assay (Fig.
1A) which measures NER, the primary
pathway for repair of UV-induced DNA lesions (7, 9). Vectors
encoding Tax or a Tax frameshift mutant was transfected into REF52
cells. Rat cells were selected for this study because they can be
transformed by Tax (12, 26, 33). Transfected cells were
blocked in the cell cycle by serum starvation and addition of
hydroxyurea and then UV irradiated to induce bulky
pyrimidine-pyrimidine dimers and photoproducts. Control cells were
similarly transfected but not UV damaged. After UV treatment, cells
were labeled with [3H]thymidine. Cellular DNA repair
activity was determined by comparing the incorporation of
[3H]thymidine into irradiated and nonirradiated cells
that had been similarly transfected. Since hydroxyurea was included to
block DNA replication, [3H]thymidine incorporation served
as a measure of DNA repair. Irradiated cells that received control
plasmid pSV2-neo or Tax frameshift mutant plasmid pSV-Tax
HC showed
high levels of [3H]thymidine incorporation due to DNA
repair synthesis. In contrast, irradiated cells that received Tax
expression plasmid pSV-Tax showed reduced [3H]thymidine
incorporation, indicating inhibition of DNA repair (Fig. 1A). At the
highest concentration of Tax tested, [3H]thymidine
incorporation was reduced to approximately 50% of that of irradiated,
non-Tax-expressing cells. The Tax-dependent reduction of DNA repair was
similar to that observed in cells from xeroderma pigmentosum patients,
which have well-characterized defects in NER (2, 14).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Dose-dependent inhibition of cellular DNA repair by Tax.
(A) UDS assay. REF52 fibroblasts were transfected with increasing
concentrations of Tax expression plasmid pSV-Tax (0.5 to 2 µg) or 2 µg of negative control plasmid pSV-Tax HC (a Tax frameshift mutant
plasmid) or pSV2-neo. The cells were serum starved, one dish of each
duplicate was UV irradiated, and all cells were labeled with
[3H]thymidine for 3 h. After labeling, the cells
were lysed and the precipitated DNA was counted. The percent repair
activity was calculated as described in Materials and Methods. The
error bars indicate the standard deviations of three replicates. (B)
HCR assay. The pMSV-Luc plasmid was UV irradiated and cotransfected
into REF52 fibroblasts with increasing concentrations of Tax expression
plasmid pCMV-Tax (0.25 to 1 µg) or 1 µg of negative control
backbone plasmid pCMV-1. Duplicate dishes received the same
transfection mixture except that the pMSV-Luc plasmid was not
irradiated in one dish. Forty hours following transfection, the cells
were harvested and luciferase and CAT assays were performed. Percent
repair activity was calculated as described in Materials and Methods.
The error bars indicate the standard deviations of three replicates.
|
|
An HCR assay (
1) was also used to measure the effect of Tax
on NER (Fig.
1B). In this assay, a reporter plasmid was UV
treated to
induce DNA damage prior to transfection. HCR is a particularly
good
measure of NER since only the reporter, and not the cells,
is damaged
by UV exposure, thus eliminating effects of DNA damage
directly on DNA
repair or cell cycle regulatory genes. A reporter
plasmid (pMSV-Luc)
was UV irradiated or mock treated and then
transfected into REF52 cells
together with Tax expression vector
pCMV-Tax or vector backbone pCMV-1.
We have previously demonstrated
that Tax does not affect luciferase
expression regulated by the
murine sarcoma virus promoter (data not
shown). Since UV-induced
lesions provide a strong block to
transcription, luciferase expression
is reduced and only rescued if the
damaged plasmid is repaired.
If NER activity is inhibited, the damaged
plasmid will not be
repaired and luciferase expression will not be
rescued. Thus,
luciferase expression represents the ability of the cell
to carry
out NER. Cotransfection with backbone vector pCMV-1 allowed
repair
of the damaged luciferase reporter and rescue of luciferase
activity
by host repair machinery. The luciferase activity in cells
cotransfected
with pCMV-Tax and the damaged reporter plasmid was
approximately
30% of that of cells in the absence of Tax, indicating
that Tax
reduced host NER
activity.
Transactivation of the PCNA promoter by Tax mutants.
We have
previously demonstrated that Tax can activate PCNA expression through a
novel Tax-responsive motif in the PCNA promoter which does not require
either cyclic AMP response element (CRE) binding protein or NF-
B
(28), and elevated levels of PCNA have been shown to allow
synthesis in the presence of DNA damage (23). To determine
whether Tax inhibition of cellular DNA repair synthesis requires
activation of PCNA gene expression, a set of 38 mutant Tax expression
vectors (31) were characterized. The abilities of these
mutant proteins to transactivate the PCNA promoter (data not shown)
were compared with their previously reported abilities to activate CRE-
and NF-
B-dependent promoters. The phenotypes segregated into four
groups represented by the mutants shown in Fig.
2A. A representative Tax mutant (M3, M22,
M47, or M32) from each phenotypic group, as well as wild-type Tax, was
cotransfected into REF52 cells with a CAT reporter containing the
Tax-responsive element of the human PCNA promoter. Each of these
mutants has previously been shown to localize predominantly in the
nucleus (31). CAT assays were performed to determine the
abilities of the mutants to activate the PCNA promoter (Fig. 2A). The
M32 Tax mutant protein did not transactivate the PCNA promoter while
mutants M3, M22, and M47 did activate the PCNA promoter, albeit to
levels slightly lower than that of wild-type Tax (Fig. 2A and Table
1). We had previously demonstrated that
Tax activation of the PCNA promoter does not require the CRE pathway
(28). These results confirm that finding and further
demonstrate that the NF-
B pathway is not required for Tax activation
of the PCNA promoter. This screen did not identify a mutant that was
specifically defective for PCNA activation while retaining activation
of the CRE and NF-
B pathways. However, the mutant phenotypes can be
used to deduce the relationship between Tax activation of the PCNA
promoter and the role of this activation in cellular DNA repair. Before initiating this effort, it was necessary to test the abilities of the
mutants to activate endogenous PCNA protein expression.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Activation of the PCNA promoter by Tax mutants.
REF52 fibroblasts were transfected with 4 µg of the 397 PCNA CAT
reporter, 6 µg of the indicated mutant Tax protein or the pCMV-1
negative control plasmid, and 1 µg of pMSV-Luc. Fold activation was
determined by dividing the CAT activity in the presence of Tax mutant
proteins by the basal CAT activity in the presence of pCMV-1. CAT units
were normalized to luciferase values to control for transfection
efficiency. The ability of each mutant protein to activate the NF- B,
CRE, and PCNA pathways is shown. Activation of the NF- B and CRE
pathways is based on previously published data (16) and
confirmed by us (data not shown). wt, wild type. (B) Activation of
endogenous PCNA expression by Tax mutants. Twenty micrograms of the
indicated Tax mutant was transfected into 100-mm-diameter dishes of
CREF. Seventy-two hours after transfection, cells were lysed in 500 µl of reporter lysis buffer (Promega) and 20 µl of the extracts was
loaded onto duplicate sodium dodecyl sulfate-10% polyacrylamide gel
electrophoresis gels. After transfer onto Immobilon membranes
(Millipore), the membranes were probed with either a rabbit anti-Tax
polyclonal antibody or a mouse anti-human PCNA monoclonal antibody
(Santa Cruz Biotech).
|
|
The effects of the wild-type and mutant Tax proteins on endogenous PCNA
protein expression were examined by Western blot analysis
of
transfected cells. Wild-type and mutant Tax proteins were expressed
at
similar levels (Fig.
2B). Cells transfected with wild-type
Tax or
mutants that reduced DNA repair (M3, M22, and M47) displayed
an
approximately fourfold increase in total endogenous PCNA expression
(Fig.
2B). Expression of endogenous PCNA protein in the absence
of Tax
(mock transfection) was similar to that of cells in the
presence of the
M32 Tax mutant that failed to reduce DNA repair
(1.6-fold). The PCNA
doublet observed in cells expressing wild-type
and mutant Tax is
presumed to represent the phosphorylated and
unphosphorylated forms of
PCNA (
27). These results are consistent
with a previous
report that endogenous PCNA is overexpressed in
the HTLV-1-transformed
Molt-4 T-cell line (
5). It has been
shown that PCNA
expression is increased in transformed cells from
1.7-fold to 9.3-fold
(
4), and in normal cells, the fluctuation
of PCNA expression
throughout the cell cycle is about 2.7-fold
(
3). Therefore,
the fourfold increase in endogenous PCNA expression
induced by Tax is
likely to be biologically
significant.
The ability of Tax to inhibit NER correlates with its ability to
transactivate the PCNA promoter.
Tax mutants were transfected into
REF52 cells to determine their effect on cellular DNA repair activity
by using both UDS and HCR assays. In the UDS assay, the M32 Tax mutant
that failed to transactivate the PCNA promoter showed minimal effects
on NER (Fig. 3A) with repair activity
greater than 75% of that of irradiated cells transfected with the
control plasmid. In contrast, those Tax mutants that transactivated the
PCNA promoter (M3, M22, and M47) retained the ability to reduce NER,
with repair activity equal to or less than 50% of that of irradiated
cells transfected with the control plasmid. These results showed that
the ability of Tax to reduce NER correlated with its ability to
transactivate PCNA but did not require functional NF-
B and CRE
pathways.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Effects of Tax mutant proteins on cellular DNA repair
synthesis. The abilities of the M3, M22, M47, and M32 Tax mutants to
impair cellular DNA synthesis were tested. (A) UDS assay. (B) HCR
assay. The experiments were performed as described in the legend to
Fig. 1. wt, wild type.
|
|
The ability of Tax mutants to inhibit NER activity was also examined by
using the HCR assay (Fig.
3B). Cells expressing the
M32 Tax mutant that
did not transactivate the PCNA promoter showed
NER activity similar to
that of non-Tax-expressing cells. In contrast,
mutants M3, M22, and
M47, which retained transactivation of the
PCNA promoter, also retained
the ability to reduce NER, although
they were somewhat less efficient
in this activity than wild-type
Tax (Table
1). In Table
1, the ability
of Tax mutants to activate
the PCNA promoter, as well as CRE- and
NF-

B-dependent promoters,
is compared with the reduction in NER
induced by the mutants in
the HCR assay. In this comparison, it is
clear that inhibition
of NER correlates most closely with the ability
to activate PCNA
gene expression. Thus, overexpression of PCNA protein
induced
by Tax may play a central role in its ability to reduce
cellular
DNA
repair.
Direct overexpression of PCNA reduces NER.
The M32 mutant Tax
protein was defective in several biological activities, including
activation of PCNA gene expression, as well as activation of CRE- and
NF-
B-dependent promoters. An HCR assay was used to determine whether
direct overexpression of PCNA would affect DNA repair (Fig.
4). UV-irradiated reporter plasmid pMSV-Luc was transfected into CREF together with increasing
concentrations of a PCNA expression vector or antisense PCNA expression
vector. Overexpression of PCNA in these cells resulted in a
dose-dependent reduction in NER, suggesting that elevated levels of
PCNA may inhibit DNA repair. These results are consistent with our
hypothesis that the Tax-mediated increase in PCNA expression is
responsible for the reduced NER observed in Tax-expressing cells. This
activity may predispose cells to accumulate DNA damage and contribute
to HTLV-1 transformation.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of PCNA overexpression on NER. A host cell
reactivation assay was used to measure NER. The pMSV-Luc plasmid was UV
irradiated and cotransfected into CREF with pSV-neo (1 µg), various
amounts of a PCNA expression plasmid (1, 2, or 4 µg), or 4 µg of
ANCP. Duplicate dishes received the same transfection mixture, except
that the pMSV-Luc plasmid was not irradiated in one dish. Forty hours
following transfection, the cells were harvested and luciferase and CAT
assays were performed. Luciferase activity was normalized to CAT
expression to correct for the difference in transfection efficiency.
Percent repair activity was calculated as described in Materials and
Methods. The error bars indicate the standard deviations of three
replicates.
|
|
 |
DISCUSSION |
This study investigated the possibility that HTLV-1 Tax may
contribute to genome instability by negatively influencing NER. We
demonstrated that Tax expression reduced NER and that this reduction
correlated closely with Tax transactivation of PCNA gene expression.
These results support a causal relationship between Tax activation of
PCNA gene expression and reduced DNA repair capacity in Tax-expressing
cells. Other viral transforming proteins, such as hepatitis B virus X
(2) and human papillomavirus E6 (8), have also
been shown to disrupt cellular DNA repair, suggesting that this may be
a common feature by which viruses transform cells.
Cellular transformation is thought to proceed by sequential steps, and
accumulation of DNA mutations is one feature common to many transformed
cells. It has been proposed that induction of a mutator phenotype
(19) that allows an increase in the mutation rate is likely
to be an early step in tumor progression. An increased mutation rate
can be achieved by replication of damaged DNA such that the damage
becomes fixed in the genome. Further amplification of the mutation rate
could result if the cell's DNA repair capacity were reduced, in
combination with the ability to replicate damaged DNA. This mutator
phenotype model predicts that disruption of cellular mechanisms that
coordinate DNA replication and repair may play an important role in transformation.
Despite accumulating knowledge regarding transcription regulation by
Tax, it remains unclear how its diverse biological activities contribute to cell transformation. We hypothesize that the
HTLV-1-transforming protein Tax can induce a mutator phenotype by
altering the cellular environment such that DNA repair capacity is
reduced and the ability to replicate DNA through damage is increased.
The resulting phenotype would favor accumulation of DNA mutations and
may lay the foundation for subsequent steps in HTLV-1 transformation.
The studies presented here address the first aspect of this hypothesis,
demonstrating that Tax can reduce the cell's ability to repair DNA damage.
Although not directly addressed in this study, the ability of Tax to
stimulate PCNA gene expression may also contribute to the second step
of our mutator phenotype model of Tax transformation by promoting
replication through DNA damage. This is suggested by previous
observations that PCNA overexpression promotes DNA replication, even in
the presence of template lesions, and increases nucleotide
misincorporation rates (18, 23). Thus, activation of PCNA
gene expression by Tax may contribute to genome instability by allowing
replication through DNA damage. Additional studies are necessary to
determine whether Tax can, indeed, stimulate replication of damaged DNA.
PCNA is a required cofactor of DNA Pol
, an enzyme involved in both
DNA replication and repair. Increasing the PCNA-to-Pol
ratio can
have a significant impact on the functions of Pol
in DNA
replication. The present study provides the first evidence that excess
PCNA can inhibit DNA repair and implies that excess PCNA may deregulate
Pol
DNA repair activity.
Three major DNA excision repair pathways have been described: base
excision repair, NER, and mismatch repair. Of the five characterized
nuclear DNA polymerases, DNA Pol
is responsible for base excision
repair and DNA Pol
and
are responsible for both NER and
mismatch repair. Tax has previously been shown to repress expression of
the DNA Pol
promoter, and it was proposed that this activity may
allow accumulation of DNA damage (15). In this report, we
show that Tax reduces NER and that this effect correlates with its
ability to activate PCNA gene expression. The presence of excess PCNA
may reduce NER by disrupting Pol
repair activity. This effect, in
combination with the ability of excess PCNA to stimulate DNA
replication by Pol
(18, 23), could result in replication
of damaged DNA. Since Pol
is involved in NER, as well as mismatch
repair, these results, together with earlier studies showing Tax
repression of the Pol
promoter, predict that Tax has the ability to
disrupt all three major DNA excision repair pathways.
Although we propose that inhibition of DNA repair synthesis may play an
important role in Tax-mediated transformation, other steps are
certainly required. Tax has been shown to activate a large number of
cellular genes, many of which have been implicated in the
transformation process. The panel of Tax mutants used in this study
demonstrated that activation of CRE- or NF-
B-dependent genes is not
required for Tax activation of the PCNA promoter or for inhibition of
DNA repair synthesis (Table 1). This finding is supported by our
previous report that Tax can activate the PCNA promoter through an
element which does not contain CRE binding protein- or NF-
B-binding
sites (28). However, CRE- and NF-
B-dependent genes are
likely to play important roles at later stages of Tax transformation
(32, 35).
A reduced ability to efficiently repair DNA damage, coupled with an
ability to stimulate DNA replication and cell proliferation, would be
expected to introduce random mutations into the genome. Thus, the
ability of Tax to reduce NER provides a basis for the long and variable
period of clinical latency before the onset of ATL and the development
of ATL in only a low percentage of infected individuals. In addition,
the ability of Tax to disrupt cellular DNA repair may explain why ATL
cells have a high incidence of chromosomal instability and abnormalities.
 |
ACKNOWLEDGMENTS |
We thank Steve Ressler and Sherry Becker for helpful discussions
and Larry Donehower, Betty Slagle, and John Brady for critical evaluation of the manuscript.
This work was supported by grants from the National Institutes of
Health and the American Cancer Society to S.J.M.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Baylor College
of Medicine, Division of Molecular Virology, One Baylor Plaza, Houston, TX 77030. Phone: (713) 798-4440. Fax: (713) 798-3490. E-mail: susanm{at}bcm.tmc.edu.
 |
REFERENCES |
| 1.
|
Athas, W. F.,
M. A. Hedayati,
G. M. Matanoski,
E. R. Farmer, and L. Grossman.
1991.
Development and field-test validation of an assay for DNA repair in circulating human lymphocytes.
Cancer Res.
51:5786-5793[Abstract/Free Full Text].
|
| 2.
|
Becker, S. A.,
T. H. Lee,
J. S. Butel, and B. L. Slagle.
1998.
Hepatitis B virus X protein interferes with cellular DNA repair.
J. Virol.
72:266-272[Abstract/Free Full Text].
|
| 3.
|
Bravo, R., and J. E. Celis.
1980.
Gene expression in normal and virally transformed mouse 3T3 and hamster BHK21 cells.
Exp. Cell Res.
127:249-260[Medline].
|
| 4.
|
Bravo, R., and J. E. Celis.
1982.
Human proteins sensitive to neoplpastic transformation in cultured epithelial and fibroblast cells.
Clin. Chem.
28:949-954[Abstract].
|
| 5.
|
Celis, J. E.,
R. Bravo,
P. M. Larsen, and S. J. Fey.
1984.
Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells.
Leuk. Res.
8:143-157[Medline].
|
| 6.
|
Chieco-Bianchi, L.,
D. Saggioro,
A. DelMistro,
A. Montaldi,
F. Majone, and A. G. Levis.
1988.
Chromosome damage induced in cord blood T-lymphocytes infected in vitro by HTLV-I.
Leukemia
2:223s-232s.
|
| 7.
|
Fautz, R.,
B. Husein,
E. Efstathiou, and C. Hechenberger-Freudi.
1993.
Assessment of the relation between the initial viability and the attachment of freshly isolated rat hepatocytes used for the in vivo/in vitro DNA repair assay (UDS).
Mutat. Res.
291:21-27[Medline].
|
| 8.
|
Ford, J. M.,
E. L. Baron, and P. C. Hanawalt.
1998.
Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation.
Cancer Res.
58:599-603[Abstract/Free Full Text].
|
| 9.
|
Friedberg, E. C.,
G. C. Walker, and W. Siede.
1995.
DNA repair and mutagenesis.
American Society for Microbiology, Washington, D.C.
|
| 10.
|
Fujita, K.,
Y. Yamasaki,
H. Sawada,
Y. Izumi,
S. Fukuhara, and H. Uchino.
1989.
Cytogenetic studies on the adult T cell leukemia in Japan.
Leuk. Res.
13:535-543[Medline].
|
| 11.
|
Grassmann, R.,
S. Berchtold,
I. Radant,
M. Alt,
B. Fleckenstein,
J. G. Sodroski,
W. A. Haseltine, and U. Ramstedt.
1992.
Role of human T-cell leukemia virus type I X region proteins in immortalization of primary human lymphocytes in culture.
J. Virol.
66:4570-4575[Abstract/Free Full Text].
|
| 12.
|
Hinrichs, S. H.,
M. Nerenberg,
R. K. Reynolds,
G. Khoury, and G. Jay.
1987.
A transgenic mouse model for human neurofibromatosis.
Science
237:1340-1343[Abstract/Free Full Text].
|
| 13.
|
Hinuma, Y.,
K. Nagata,
M. Misoka,
T. Nakai,
T. Matsumoto,
K. Kiroshita,
S. Shirakwa, and I. Miyoshi.
1981.
Adult T-cell leukemia: antigen in ATL cell line and detection of antibodies to the antigen in human sera.
Proc. Natl. Acad. Sci. USA
78:6476-6480[Abstract/Free Full Text].
|
| 14.
|
Hoejmakers, J. H. J.
1993.
Nucleotide excision repair II: from yeast to mammals.
Trends Genet.
9:211-217[Medline].
|
| 15.
|
Jeang, K.-T.,
S. G. Widen,
O. J. Semmes, and S. H. Wilson.
1990.
HTLV-1 trans-activator protein, Tax, is a trans-repressor of the human -polymerase gene.
Science
247:1082-1084[Abstract/Free Full Text].
|
| 16.
|
Kamada, N.,
M. Sakurai,
K. Miyamoto,
A. Sancar,
N. Sadamori,
S. Fukuhara,
S. Abe,
Y. Shiraishi,
T. Abe,
Y. Kaneko, and M. Shimoyama.
1992.
Chromosome abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report.
Cancer Res.
52:1482-1493.
|
| 17.
|
Kelman, Z.
1997.
PCNA: structure, functions and interactions.
Oncogene
14:629-640[Medline].
|
| 18.
|
Li, R.,
S. Waga,
G. J. Hannon,
D. Beach, and B. Stillman.
1994.
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.
Nature
371:534-537[Medline].
|
| 19.
|
Loeb, L. A.
1991.
Mutator phenotype may be required for multistage carcinogenesis.
Cancer Res.
51:3075-3079[Free Full Text].
|
| 20.
|
Macera, M. J.,
P. Hyde,
N. Peddanna,
P. Szabo,
S. K. Gogineni, and R. S. Verma.
1996.
T-cell receptor J 1/ 2 locus rearrangements in an HTLV-1-positive T-cell lymphoma with complex chromosomal aberrations.
Am. J. Hematol.
52:53-57[Medline].
|
| 21.
|
Majone, F.,
O. J. Semmes, and K.-T. Jeang.
1993.
Induction of micronuclei by HTLV-I Tax: a cellular assay for function.
Virology
193:456-459[Medline].
|
| 22.
|
Maruyama, K.,
T. Fukushima,
K. Kawamura, and S. Mochizuki.
1990.
Chromosome and gene rearrangements in immortalized human lymphocytes infected with human T-lymphotropic virus type I.
Cancer Res.
50:5697s-5702s[Abstract/Free Full Text].
|
| 23.
|
Mozzherin, D. J.,
S. Shibutani,
C. K. Tan,
K. M. Downey, and P. A. Fisher.
1997.
Proliferating cell nuclear antigen promotes DNA synthesis past template lesions by mammalian DNA polymerase .
Proc. Natl. Acad. Sci. USA
94:6126-6131[Abstract/Free Full Text].
|
| 24.
|
Nakanishi, M.,
R. S. Robetorye,
O. M. Pereira-Smith, and J. R. Smith.
1995.
The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition.
J. Biol. Chem.
270:17060-17063[Abstract/Free Full Text].
|
| 25.
|
Poiesz, B. J.,
F. W. Ruscetti,
A. F. Gazdar,
P. A. Bunn,
J. D. Minna, and R. C. Gallo.
1980.
Detection and isolation of type C retrovirus particles from freshly cultured lumphocytes of a patient with cutaneous T cell lymphoma.
Proc. Natl. Acad. Sci. USA
77:7415-7419[Abstract/Free Full Text].
|
| 26.
|
Pozzatti, R.,
J. Vogel, and G. Jay.
1990.
The human T-lymphotropic virus I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells.
Mol. Cell. Biol.
10:413-417[Abstract/Free Full Text].
|
| 27.
|
Prosperi, E.,
A. I. Scovassi,
L. A. Stivala, and L. Bianchi.
1994.
Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with cyclin D1 and cyclin A.
Exp. Cell Res.
215:257-262[Medline].
|
| 28.
|
Ressler, S.,
G. F. Morris, and S. J. Marriott.
1997.
Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter.
J. Virol.
71:1181-1190[Abstract].
|
| 29.
|
Rowley, J. D.,
J. M. Haren,
F. Wong-Staal,
G. Franchini,
R. C. Gallo, and W. Blattner.
1984.
Chromosome patterns in cells from patients positive for human T-cell leukemia/lymphoma virus, p. 85-89.
In
R. C. Gallo, M. E. Essex, and L. Gross (ed.), Human T-cell leukemia/lymphoma virus. Cold Spring Harbor Laboratory, New York, N.Y.
|
| 30.
|
Saggioro, D.,
F. Majone,
M. Forino,
L. Turchetto,
A. Leszl, and L. Chieco-Bianchi.
1994.
Tax protein of human T-lymphotropic virus type I triggers DNA damage.
Leuk. Lymphoma
12:281[Medline].
|
| 31.
|
Smith, M. R., and W. C. Greene.
1990.
Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes.
Genes Dev.
4:1875-1885[Abstract/Free Full Text].
|
| 32.
|
Smith, M. R., and W. C. Greene.
1991.
Type I human T cell leukemia virus Tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway.
J. Clin. Investig.
88:1038-1042.
|
| 33.
|
Tanaka, A.,
G. Takahashi,
S. Yamaoka,
T. Nosaka,
M. Maki, and M. Hatanaka.
1990.
Oncogenic transformation by the tax gene of human T cell leukemia virus type I in vitro.
Proc. Natl. Acad. Sci. USA
87:1071-1075[Abstract/Free Full Text].
|
| 34.
|
Waga, S.,
G. J. Hannon,
D. Beach, and B. Stillman.
1994.
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.
Nature
369:574-578[Medline].
|
| 35.
|
Yamaoka, S.,
H. Inoue,
M. Sakurai,
T. Sugiyama,
M. Hazama,
T. Yamada, and M. Hatanaka.
1996.
Constitutive activation of NF- B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein.
EMBO J.
15:873-887[Medline].
|
Journal of Virology, May 1999, p. 4299-4304, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Durkin, S. S., Guo, X., Fryrear, K. A., Mihaylova, V. T., Gupta, S. K., Belgnaoui, S. M., Haoudi, A., Kupfer, G. M., Semmes, O. J.
(2008). HTLV-1 Tax Oncoprotein Subverts the Cellular DNA Damage Response via Binding to DNA-dependent Protein Kinase. J. Biol. Chem.
283: 36311-36320
[Abstract]
[Full Text]
-
Edwards, D. C., Marriott, S. J.
(2008). Human T-Cell Leukemia Virus Type 1 Tax Relieves Repression of Proliferating Cell Nuclear Antigen Gene Expression. J. Virol.
82: 11714-11722
[Abstract]
[Full Text]
-
Chen, Y.-R., Liu, M.-T., Chang, Y.-T., Wu, C.-C., Hu, C.-Y., Chen, J.-Y.
(2008). Epstein-Barr Virus Latent Membrane Protein 1 Represses DNA Repair through the PI3K/Akt/FOXO3a Pathway in Human Epithelial Cells. J. Virol.
82: 8124-8137
[Abstract]
[Full Text]
-
Lu, C.-C., Chen, Y.-C., Wang, J.-T., Yang, P.-W., Chen, M.-R.
(2007). Xeroderma pigmentosum C is involved in Epstein Barr virus DNA replication. J. Gen. Virol.
88: 3234-3243
[Abstract]
[Full Text]
-
Gupta, S. K., Guo, X., Durkin, S. S., Fryrear, K. F., Ward, M. D., Semmes, O. J.
(2007). Human T-cell Leukemia Virus Type 1 Tax Oncoprotein Prevents DNA Damage-induced Chromatin Egress of Hyperphosphorylated Chk2. J. Biol. Chem.
282: 29431-29440
[Abstract]
[Full Text]
-
Gatza, M. L., Marriott, S. J.
(2006). Genotoxic Stress and Cellular Stress Alter the Subcellular Distribution of Human T-Cell Leukemia Virus Type 1 Tax through a CRM1-Dependent Mechanism.. J. Virol.
80: 6657-6668
[Abstract]
[Full Text]
-
Waldele, K., Silbermann, K., Schneider, G., Ruckes, T., Cullen, B. R., Grassmann, R.
(2006). Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood
107: 4491-4499
[Abstract]
[Full Text]
-
Watanabe, M., Ohsugi, T., Shoda, M., Ishida, T., Aizawa, S., Maruyama-Nagai, M., Utsunomiya, A., Koga, S., Yamada, Y., Kamihira, S., Okayama, A., Kikuchi, H., Uozumi, K., Yamaguchi, K., Higashihara, M., Umezawa, K., Watanabe, T., Horie, R.
(2005). Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-{kappa}B, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood
106: 2462-2471
[Abstract]
[Full Text]
-
Peloponese, J.-M. Jr., Iha, H., Yedavalli, V. R. K., Miyazato, A., Li, Y., Haller, K., Benkirane, M., Jeang, K.-T.
(2004). Ubiquitination of Human T-Cell Leukemia Virus Type 1 Tax Modulates Its Activity. J. Virol.
78: 11686-11695
[Abstract]
[Full Text]
-
Sinha-Datta, U., Horikawa, I., Michishita, E., Datta, A., Sigler-Nicot, J. C., Brown, M., Kazanji, M., Barrett, J. C., Nicot, C.
(2004). Transcriptional activation of hTERT through the NF-{kappa}B pathway in HTLV-I-transformed cells. Blood
104: 2523-2531
[Abstract]
[Full Text]
-
Jeang, K.-T., Giam, C.-z., Majone, F., Aboud, M.
(2004). Life, Death, and Tax: Role of HTLV-I Oncoprotein in Genetic Instability and Cellular Transformation. J. Biol. Chem.
279: 31991-31994
[Full Text]
-
Twizere, J.-C., Kruys, V., Lefebvre, L., Vanderplasschen, A., Collete, D., Debacq, C., Lai, W. S., Jauniaux, J.-C., Bernstein, L. R., Semmes, O. J., Burny, A., Blackshear, P. J., Kettmann, R., Willems, L.
(2003). Interaction of Retroviral Tax Oncoproteins With Tristetraprolin and Regulation of Tumor Necrosis Factor-{alpha} Expression. JNCI J Natl Cancer Inst
95: 1846-1859
[Abstract]
[Full Text]
-
Tripp, A., Liu, Y., Sieburg, M., Montalbano, J., Wrzesinski, S., Feuer, G.
(2003). Human T-Cell Leukemia Virus Type 1 Tax Oncoprotein Suppression of Multilineage Hematopoiesis of CD34+ Cells In Vitro. J. Virol.
77: 12152-12164
[Abstract]
[Full Text]
-
Haoudi, A., Daniels, R. C., Wong, E., Kupfer, G., Semmes, O. J.
(2003). Human T-cell Leukemia Virus-I Tax Oncoprotein Functionally Targets a Subnuclear Complex Involved in Cellular DNA Damage-Response. J. Biol. Chem.
278: 37736-37744
[Abstract]
[Full Text]
-
Riva, F., Zuco, V., Vink, A. A., Supino, R., Prosperi, E.
(2001). UV-induced DNA incision and proliferating cell nuclear antigen recruitment to repair sites occur independently of p53-replication protein A interaction in p53 wild type and mutant ovarian carcinoma cells. Carcinogenesis
22: 1971-1978
[Abstract]
[Full Text]
-
Ruckes, T., Saul, D., Van Snick, J., Hermine, O., Grassmann, R.
(2001). Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood
98: 1150-1159
[Abstract]
[Full Text]
-
Mansky, L. M.
(2001). Sorting Out Mutations in Human T-Cell Leukemia Virus Type 1 Proviruses During In Vivo Clonal Expansion. JNCI J Natl Cancer Inst
93: 336-337
[Full Text]
-
Mortreux, F., Leclercq, I., Gabet, A.-S., Leroy, A., Westhof, E., Gessain, A., Wain-Hobson, S., Wattel, E.
(2001). Somatic Mutation in Human T-Cell Leukemia Virus Type 1 Provirus and Flanking Cellular Sequences During Clonal Expansion In Vivo. JNCI J Natl Cancer Inst
93: 367-377
[Abstract]
[Full Text]
-
Portis, T., Grossman, W. J., Harding, J. C., Hess, J. L., Ratner, L.
(2001). Analysis of p53 Inactivation in a Human T-Cell Leukemia Virus Type 1 Tax Transgenic Mouse Model. J. Virol.
75: 2185-2193
[Abstract]
[Full Text]
-
Nicot, C., Mahieux, R., Takemoto, S., Franchini, G.
(2000). Bcl-XL is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood
96: 275-281
[Abstract]
[Full Text]
-
Butel, J. S.
(2000). Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis
21: 405-426
[Abstract]
[Full Text]
-
Franchini, G., Ambinder, R. F., Barry, M.
(2000). Viral Disease in Hematology. ASH Education Book
2000: 409-423
[Abstract]
[Full Text]
-
Kibler, K. V., Jeang, K.-T.
(1999). Taxing the Cellular Capacity for Repair: Human T-Cell Leukemia Virus Type 1, DNA Damage, and Adult T-Cell Leukemia. JNCI J Natl Cancer Inst
91: 903-904
[Full Text]
-
Majone, F., Jeang, K.-T.
(2000). Clastogenic Effect of the Human T-cell Leukemia Virus Type I Tax Oncoprotein Correlates with Unstabilized DNA Breaks. J. Biol. Chem.
275: 32906-32910
[Abstract]
[Full Text]
-
Kao, S.-Y., Lemoine, F. J., Marriott, S. J.
(2000). Suppression of DNA Repair by Human T Cell Leukemia Virus Type 1 Tax Is Rescued by a Functional p53 Signaling Pathway. J. Biol. Chem.
275: 35926-35931
[Abstract]
[Full Text]
-
Lemoine, F. J., Marriott, S. J.
(2001). Accelerated G1 Phase Progression Induced by the Human T Cell Leukemia Virus Type I (HTLV-I) Tax Oncoprotein. J. Biol. Chem.
276: 31851-31857
[Abstract]
[Full Text]